Related Experiment Video
Updated: Feb 15, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer
Jie Han1, Dakota Jackson1, Janette Holm2
1Division of Gastroenterology, Department of Internal Medicine, Baylor Scott & White Research Institute, Baylor University Medical Center, Dallas, TX 75204.
Urine d-2-hydroxyglutarate (D2HG) and low tissue d-2-hydroxyglutarate dehydrogenase (D2HGDH) expression indicate higher risk for colon cancer progression in colitis patients. This pathway offers potential therapeutic targets for colitis-associated colon cancer.
Area of Science:
- Biochemistry
- Oncology
- Gastroenterology
Background:
- d-2-hydroxyglutarate (D2HG) is a metabolic byproduct of the tricarboxylic acid cycle.
- d-2-hydroxyglutarate dehydrogenase (D2HGDH) converts D2HG to α-ketoglutarate.
- Altered D2HG metabolism is implicated in cancer development.
Purpose of the Study:
- To investigate the role of the D2HG/D2HGDH pathway in colitis-associated colon cancer (CAC).
- To identify D2HG and D2HGDH as potential biomarkers for CAC progression.
- To explore the D2HG/D2HGDH pathway as a therapeutic target for CAC.
Main Methods:
- Utilized a mouse model of colitis-associated colon cancer.
- Measured urine D2HG levels and colonic D2HGDH expression in mice and ulcerative colitis (UC) patients.
- Investigated the effect of D2HG injection on colitis recovery and tumorigenesis.
- Examined the role of Hypoxia-inducible factor (Hif)-1α in regulating D2HGDH transcription.
Main Results:
- In a mouse CAC model, urine D2HG levels during colitis correlated with polyp counts and dysplasia severity.
- D2HG injection delayed colitis recovery and exacerbated tumorigenesis in mice.
- Colonic D2HGDH expression was decreased at baseline in UC patients who later developed cancer.
- Hif-1α was identified as a key regulator of D2HGDH transcription.
Conclusions:
- Urine D2HG and colonic D2HGDH expression serve as valuable biomarkers for identifying patients at high risk of progressing from colitis to cancer.
- The D2HG/D2HGDH metabolic pathway presents a promising therapeutic target for treating CAC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Elevation of Intermediate Points on Vertical Curves
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

